MST1 Suppresses Disturbed Flow Induced Atherosclerosis
Meixi Quan1,2, Huizhen Lv1,2, Zening Liu2
1Tianjin Institute of Cardiology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Second Hospital of Tianjin Medical University (M.Q., H.L., D.A.), Tianjin Medical University, China.
Mammalian sterile 20-like kinase 1 (MST1) inhibition drives atherosclerosis by disrupting endothelial cell function via the connexin 43 (Cx43) axis under disturbed blood flow. Targeting this MST1-Cx43 pathway offers a novel therapeutic strategy for atherosclerosis.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Mechanobiology
Background:
- Atherosclerosis develops at arterial sites with disturbed blood flow.
- The role of MST1 (mammalian sterile 20-like kinase 1) in disturbed flow-induced endothelial cell (EC) activation and atherosclerosis is not well understood.
Purpose of the Study:
- To investigate the role of MST1 in endothelial dysfunction and atherosclerosis under disturbed blood flow.
- To elucidate the molecular mechanisms linking MST1, EC activation, and atherogenesis.
Main Methods:
- Utilized EC-specific Mst1-deficient mice on an ApoE background in a carotid artery ligation model.
- Employed mass spectrometry, immunoprecipitation, and dye uptake assays.
- Applied oscillatory shear stress to human and mouse endothelial cells in vitro.
Main Results:
- Endothelial MST1 phosphorylation decreased under oscillatory shear stress.
- MST1 deficiency exacerbated EC activation and atherosclerosis, which was reversed by MST1 re-expression.
- MST1 inhibition reduced Cx43 (connexin 43) phosphorylation and hemichannel activity, contributing to EC dysfunction and atherosclerosis.
- Filamin B facilitates Cx43 translocation to lipid rafts, promoting hemichannel opening.
Conclusions:
- The MST1-Cx43 axis is critical in driving endothelial dysfunction and atherosclerosis under disturbed flow.
- Inhibition of this axis represents a potential therapeutic target for atherosclerosis treatment.
More Related Videos
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
07:51Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
Published on: January 13, 2012
Related Concept Videos
Atherosclerosis III: Management
Mitral Stenosis I: Introduction
Atherosclerosis I: Introduction
